Quality of Life and Chemotherapy-related Symptoms of Turkish Cancer Children Undergoing Chemotherapy

dc.contributor.authorArslan, Fatma Tas
dc.contributor.authorBasbakkal, Zumrut
dc.contributor.authorKantar, Mehmet
dc.date.accessioned2020-03-26T18:43:04Z
dc.date.available2020-03-26T18:43:04Z
dc.date.issued2013
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractThis cross-sectional and descriptive study was designed to determine symptoms emerging due to chemotherapy treatment and their effects on children's quality of life. The research was carried out between February 2008 and February 2009 at the pediatric oncology clinics in four hospitals, focusing on 93 patients receiving chemotherapy. A survey form, the Pediatric Quality of Life Inventory (PedsQL 4.0) and the Memorial Symptom Assessment Scale (MSAS) were used as data collection tools. Chi-square and Student t tests were performed for data analysis. Some 51.6% of the children were aged 13-15 years old, and 51.8% were boys and 50.5% were diagnosed as having solid tumors. There were significant relations between: antimetabolite chemotherapeutics and feeling irritable and worrying (p=0.001, p=0.030); vinkoalkaloid and numbness/tingling in hands/feet (p=0.043); antracyclines and lack of energy and skin changes (p=0.021, p=0.004); and corticosteroids and lack of appetite, nausea and sadness (p=0.008, p=0.009, p=0.009). Several symptoms such as feeling sad, worrying and feeling irritable caused a significant decrease in the total domain of quality of life scores (p=0.034, p=0.012, p=0.010, respectively). Chemotherapeutic drugs can cause symptoms that can seriously affect quality of life in children.en_US
dc.description.sponsorshipSelcuk University Scientific Research Project UnitSelcuk Universityen_US
dc.description.sponsorshipThe authors are grateful to Mehmet Orman in statistical analysis, and all children and their parents who participated in this study. This study was presented as poster paper in the 5th Europaediatrics Congress on June 23rd-26th in Wien, Austria. Poster report received external funding from Selcuk University Scientific Research Project Unit.en_US
dc.identifier.doi10.7314/APJCP.2013.14.3.1761en_US
dc.identifier.endpage1768en_US
dc.identifier.issn1513-7368en_US
dc.identifier.issue3en_US
dc.identifier.pmid23679270en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1761en_US
dc.identifier.urihttps://dx.doi.org/10.7314/APJCP.2013.14.3.1761
dc.identifier.urihttps://hdl.handle.net/20.500.12395/29763
dc.identifier.volume14en_US
dc.identifier.wosWOS:000319985400032en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherASIAN PACIFIC ORGANIZATION CANCER PREVENTIONen_US
dc.relation.ispartofASIAN PACIFIC JOURNAL OF CANCER PREVENTIONen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectChildrenen_US
dc.subjectcanceren_US
dc.subjectchemotherapyen_US
dc.subjectsymptomsen_US
dc.subjectquality of lifeen_US
dc.subjectTurkeyen_US
dc.titleQuality of Life and Chemotherapy-related Symptoms of Turkish Cancer Children Undergoing Chemotherapyen_US
dc.typeArticleen_US

Dosyalar